Pages that link to "Q48189796"
Jump to navigation
Jump to search
The following pages link to Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder (Q48189796):
Displaying 50 items.
- Calcitonin and bipolar disorder: a hypothesis revisited (Q24535700) (← links)
- Adrenergic pharmacology and cognition: focus on the prefrontal cortex (Q24684217) (← links)
- A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates (Q26786354) (← links)
- Neurobiological findings in bipolar II disorder compared with findings in bipolar I disorder (Q30981655) (← links)
- Basal ganglia volumetric studies in affective disorder: what did we learn in the last 15 years? (Q31013562) (← links)
- Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies (Q31125310) (← links)
- GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior (Q33590698) (← links)
- Striatal structure and function in mood disorders: a comprehensive review (Q33777327) (← links)
- Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models (Q33783892) (← links)
- Neuroimaging of serotonin uptake sites and antidepressant binding sites in the thalamus of humans and 'higher' animals (Q33810902) (← links)
- Neuropathology of bipolar disorder (Q34052805) (← links)
- The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues (Q34116326) (← links)
- Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies (Q34185330) (← links)
- Serotonergic dysfunction, negative mood states, and response to alcohol (Q34236249) (← links)
- Serotonin and bipolar disorder (Q34353341) (← links)
- Physiopathology of bipolar disorders: what have changed in the last 10 years? (Q34376230) (← links)
- The underlying neurobiology of bipolar disorder (Q34562614) (← links)
- Cell pathology in bipolar disorder (Q34692741) (← links)
- Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial (Q34939218) (← links)
- Pharmacotherapy of bipolar disorder: the role of atypical antipsychotics and experimental strategies (Q35011798) (← links)
- Suicidal behaviour in bipolar disorder: risk and prevention (Q35129379) (← links)
- The neurobiology of bipolar disorder (Q35576976) (← links)
- RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients (Q35662070) (← links)
- The neurobiology of bipolar disorder: findings using human postmortem central nervous system tissue. (Q35666555) (← links)
- Can body mass index help predict outcome in patients with bipolar disorder? (Q36532159) (← links)
- Serotonergic dysfunction: brain imaging and behavioral correlates (Q36547548) (← links)
- Panic comorbidity with bipolar disorder: what is the manic-panic connection? (Q36677640) (← links)
- Differences between males and females in rates of serotonin synthesis in human brain (Q36772213) (← links)
- How Childhood Maltreatment Is Related to Suicidality, Bipolarity and Central Serotonergic Activity in Patients with Major Depressive Disorder: A Cross-Sectional Pilot Study (Q36772480) (← links)
- Exercise and bipolar disorder: a review of neurobiological mediators. (Q37569847) (← links)
- Catecholamine modulation of prefrontal cortical cognitive function (Q37827944) (← links)
- Pathobiological targets of depression. (Q37831342) (← links)
- Quantitative targeted proteomics for understanding the blood-brain barrier: towards pharmacoproteomics. (Q38202164) (← links)
- Acute tryptophan depletion in bipolar disorders; literature review and directives for further research (Q38774128) (← links)
- Plasma homovanillic acid and prolactin in systemic lupus erythematosus (Q42539741) (← links)
- A change in the density of [(3)H]flumazenil, but not [(3)H]muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder (Q43751920) (← links)
- Pronounced cognitive deficits following an intravenous L-tryptophan challenge in first-degree relatives of bipolar patients compared to healthy controls (Q44374783) (← links)
- Mood state moderates the role of serotonin in cognitive biases (Q46150850) (← links)
- The Neural control of mood: The possible role of the adrenergic system in the medulla (Q46249680) (← links)
- The role of tryptophan metabolism in postpartum depression (Q47201558) (← links)
- Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function (Q48303117) (← links)
- Changes in the molecular structure of the brain in bipolar disorder: findings using human postmortem brain tissue (Q48427962) (← links)
- Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes (Q48581868) (← links)
- Reduced dopamine turnover in the basal ganglia of depressed suicides (Q48592039) (← links)
- Increased G alpha q/11 immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder (Q48764836) (← links)
- 5-HT2A receptor and bipolar affective disorder: association studies in affected patients (Q48765875) (← links)
- Anatomical MRI study of basal ganglia in bipolar disorder patients (Q48913237) (← links)
- Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects (Q49056581) (← links)
- Lay theories of bipolar disorder: the causes, manifestations and cures for perceived bipolar disorder (Q51866224) (← links)
- Local infusion of an alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys. (Q52173192) (← links)